News summary

Valorization of yak bone collagen byproducts: computational screening and experimental validation of anti-aging peptides targeting MMP-1

Source: Nature - Biotechnology • Published: 22 Oct 2026, 00:00

Summarized by Masters of Longevity from Nature - Biotechnology.

Yak collagen byproducts are profiled using computational screening and lab tests to highlight candidate anti‑aging peptides and their experimental follow-up.

Valorization of yak bone collagen byproducts: computational screening and experimental validation of anti-aging peptides targeting MMP-1
Key Takeaways
  • An ESM-2 based model AgeAttnMLP screened yak collagen sequences and achieved AUCs of 0.891 and 0.879 in validations.
  • Three peptides were prioritized and GEPGAPGE inhibited MMP-1 with an IC50 of 126 μg/mL.
  • All three peptides increased Caenorhabditis elegans lifespan, with GPSGEPGTA giving the largest effect at 7.5 mg/mL.
Read the full article at Nature - Biotechnology ↗

Continue exploring

Recommended MoL Picks

MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.MoL PickMOTS-c: Where the Evidence EndsStudies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.